AMGN vs ROOT · P/E 24, rev $36.75B vs P/E 14, rev $1.18B
Amgen Inc (AMGN) versus Root Inc (ROOT) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
Root Inc (ROOT) is a insurance - property & casualty company listed on NASDAQ.
Latest reported AMGN revenue for 2025-12-31 was $36.75B. Net income was $7.71B. Revenue was up 10.0% from 2024-12-31 to 2025-12-31. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported ROOT revenue for 2024-12-31 was $1.18B. Net income was $30.9M. Revenue was up 158.6% from 2023-12-31 to 2024-12-31. ROOT currently screens at market cap $767.6M and trailing P/E 14.3.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. ROOT currently screens at market cap $767.6M and trailing P/E 14.3.
Not investment advice. Open the AMGN and ROOT stock pages for the full models.
Not investment advice.